Have a feature idea you'd love to see implemented?
Let us know!
OKUR OnKure Therapeutics Inc.
Price (delayed)
$15.99
Market cap
$213.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.76
Enterprise value
$153.27M
Highlights
The quick ratio has soared by 155% YoY
OKUR's EPS is up by 34% year-on-year and by 28% since the previous quarter
The equity has soared by 160% since the previous quarter but it is down by 36% year-on-year
OKUR's debt is down by 42% year-on-year but it is up by 16% since the previous quarter
Key stats
What are the main financial stats of OKUR
Market
Valuations
Earnings
Shares outstanding
13.34M
Market cap
$213.3M
Enterprise value
$153.27M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.72
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$49.79M
EBITDA
-$49.57M
Free cash flow
-$49.88M
Per share
Balance sheet
Liquidity
EPS
-$11.76
Free cash flow per share
-$14.92
Book value per share
$22.14
Revenue per share
$0
TBVPS
$23.23
Total assets
$77.65M
Total liabilities
$3.63M
Debt
$665,000
Equity
$74.02M
Working capital
$73.75M
Debt to equity
0.01
Current ratio
23.71
Quick ratio
23.6
Net debt/EBITDA
1.21
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-67.5%
Return on equity
-165.6%
Return on invested capital
-148.9%
Return on capital employed
-66.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OKUR stock price
How has the OnKure Therapeutics stock price performed over time
Intraday
-0.06%
1 week
-5.38%
1 month
-13.8%
1 year
N/A
YTD
N/A
QTD
N/A
Financial performance
How have OnKure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$53.58M
Net income
-$49.81M
Gross margin
N/A
Net margin
N/A
OnKure Therapeutics's net income has increased by 24% QoQ and by 11% YoY
OnKure Therapeutics's operating income has increased by 23% from the previous quarter and by 11% YoY
Growth
What is OnKure Therapeutics's growth rate over time
Valuation
What is OnKure Therapeutics stock price valuation
P/E
N/A
P/B
0.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OKUR's EPS is up by 34% year-on-year and by 28% since the previous quarter
The equity has soared by 160% since the previous quarter but it is down by 36% year-on-year
Efficiency
How efficient is OnKure Therapeutics business performance
OnKure Therapeutics's return on invested capital has shrunk by 149% YoY and by 29% QoQ
OKUR's ROA is down by 46% year-on-year but it is up by 10% since the previous quarter
OKUR's ROE is down by 2.2% since the previous quarter
Dividends
What is OKUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OKUR.
Financial health
How did OnKure Therapeutics financials performed over time
The quick ratio has soared by 155% YoY
OnKure Therapeutics's current ratio has soared by 150% YoY
OKUR's debt is 99% smaller than its equity
The equity has soared by 160% since the previous quarter but it is down by 36% year-on-year
OKUR's debt is down by 42% year-on-year but it is up by 16% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.